Gunasekaran Sengottuvelu
Latest contributions
Step-by-step TAVI procedure in Europe and India - A review from PCR and India Valves
21 Aug 2025
Watch this replay with A.B. Gopalamurugan, B. Prendergast, G. Sengottuvelu and D. Tchetche and discuss the current state of valvular interventions globally and in India, and so much more!
Expanding indications for TAVI - moderate aortic stenosis and heart failure
09 Feb 2025 – From PCR Tokyo Valves 2025
Should you intervene earlier in patients with moderate aortic stenosis and heart failure? This session breaks down the latest trials shaping clinical decisions.
You'll get the key takeaways from EARLY TAVR, EVOLVED, TAVR UNLOAD, PROGRESS and EXPAND TAVR II (what they reveal, what they don’t and how...
TAVI complex cases: intravascular hemolysis, Heyde syndrome & more
08 Feb 2025 – From PCR Tokyo Valves 2025
This session presents a diverse array of complex TAVI cases, from interventions for paravalvular leak-induced intravascular hemolysis to cases of severe aortic tortuosity, calcification hindering valve expansion, and successful TAVI in patients with Heyde syndrome and HIV infection. Gain valuable insights into navigating these challenging scenarios.
High-risk TAVI
08 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the management of high-risk TAVI cases in this session. Discover innovative approaches, such as Impella-assisted TAVI in severe bicuspid aortic valve disease with severe left ventricular dysfunction, TAVR for pure native aortic regurgitation in surgically unfit patients, and the use of TAVI as a...
Contemporary treatment for Small Aortic Annuli in 2024
25 Nov 2024 – From PCR London Valves 2024
In this roundtable discussion, Gunasekaran Sengottuvelu, Viveka Kumar, and Haresh Mehta explore optimal treatment strategies and the selection of valve types for challenging anatomies such as small annuli—a condition prevalent in a significant portion of the Indian population.
This interview was filmed at PCR London Valves 2024:...
Align for the future with Myval THV series - From randomised trials to everyday clinical practice
25 Nov 2024 – From PCR London Valves 2024
Through the presentation of several compelling cases, including an 88-year-old male with CKD, RBBB, moderate LV dysfunction, and severe aortic stenosis, a Type 1a bicuspid native AS, and an extraordinary TAVI in an 83-year-old with acute heart failure and comorbidities, this session will dive into the...
TAVI - Advanced skills: overcoming challenges in transfemoral procedures
24 Nov 2024 – From PCR London Valves 2024
Discover how to master advanced techniques and navigate the most challenging situations in transfemoral TAVI procedures. This session will guide you through the potential pitfalls, teach you how to manage unanticipated scenarios and provide strategies for addressing complications during transcatheter heart valve (THV) deployment.
You’ll also dive...
Pre-emptive TAVI for asymptomatic severe aortic stenosis - From headlines to clinical practice
24 Nov 2024 – From PCR London Valves 2024
Is early TAVI the right choice for your asymptomatic patients with severe aortic stenosis? In this video, we break down the latest clinical trials, including EARLY TAVR and EVOLVED, to help you navigate the complex decision-making process.
Find out what these studies really tell us about the...
New data on TAVI
16 May 2024 – From EuroPCR 2024
This session presents the latest research and data on transcatheter aortic valve implantation (TAVI). It covers a range of topics, including long-term results of TAVI versus surgical aortic valve replacement in low-risk severe aortic stenosis, real-world experience with novel transcatheter heart valve devices, outcomes in patients...
Bicuspid disease - All you need to know
16 May 2024 – From EuroPCR 2024
This session is ideal if you want to understand the anatomical features of bicuspid aortic stenosis, learn about the latest post-TAVI clinical outcomes in bicuspid aortic valves, grasp key considerations for TAVI sizing in these cases, and analyze both self-expanding and balloon-expandable TAVI procedures in bicuspid...
Major Late-Breaking Trials from EuroPCR 2024
15 May 2024 – From EuroPCR 2024
This session presents the latest results from major late-breaking trials presented at EuroPCR 2024. It covers a one-month DAPT followed by 5-month ticagrelor monotherapy in acute coronary syndromes with DCB, the first TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid...
New devices for aortic intervention
18 Feb 2024 – From PCR Tokyo Valves 2024
In this session, discover a variety of abstract submissions concerning new devices for aortic intervention. Compare the clinical outcomes of the latest intra-annular devices, examine the differences in debris between SEV and PEV, and learn about PVL improvement after TAVI with a self-expanding valve.
Nightmares in TAVI: sharing solutions together
18 Feb 2024 – From PCR Tokyo Valves 2024
Consult this session to learn more about bailout techniques for TAVI during uncommon complications, such as late coronary obstruction post-TAVI, a migrated self-expandable valve, or a C-tab induced iatrogenic thoracic aortic dissection after Evolut FX implantation.
Rapid-fire - Complex anatomy in TAVI
17 Feb 2024 – From PCR Tokyo Valves 2024
This session of rapid-fire submitted cases focuses on solutions to complex anatomy during TAVI. Learn about a successful transfemoral TAVR using Evolut FX for complex bicuspid aortic valve stenosis, the feasibility and success of TAVI in rheumatic severe aortic stenosis, and more!
Contemporary surgical and transcatheter approaches for multivalve disease
21 Nov 2023 – From PCR London Valves 2023
Explore modern surgical and transcatheter strategies for addressing multivalve disease in this session: gain in-depth knowledge about the current approaches in both surgical and transcatheter management of multivalve disease, develop a profound understanding of algorithms guiding the identification of the dominant valve lesion and shaping procedural...
TAVI - complications
21 Nov 2023 – From PCR London Valves 2023
Because TAVI is not without risk, learn about bailout endovascular techniques to counter transcatheter aortic valve LV dislocation, analyze the cost of infectious complications caused by TAVR compared with SAVR, and discover how imaging can predict aortic root rupture or conduction abnormalities, among others.
Essentials of lifetime management of TAVI patients
21 Nov 2023 – From PCR London Valves 2023
Consult this session if you want to learn about the next generation transcatheter heart valve technology key features, procedural and clinical benefits, to learn tips and tricks for managing bicuspid and valve-in-valve interventions, and to understand procedural and clinical relevance of intermediate and XL sizes in...
Rapid-fire - Nightmares in the cathlab - Part 2
20 Nov 2023 – From PCR London Valves 2023
Calcified bifurcation lesion - LIVE case
22 Sep 2023 – From AICT-AsiaPCR 2023
A 59-year-old female patient with type 2 DM, dyslipidaemia, hypothyroidism and impaired LV function (39%) presented with multivessel disease. RCA PCI was performed 3 days ago.
The prox and mid LAD showed a severe calcified lesion including the diagonal. The lesion was prepared using a 1.25 Rotaglide™ ('single-person'...
Essentials of lifetime management in patient undergoing TAVI using novel balloon expandable Myval Octacor THV
22 Sep 2023 – From AICT-AsiaPCR 2023
This session with a LIVE case provides information about the Octacor transcatheter heart valve technology, highlighting its procedural and clinical benefits. It also covers the Octalign technique, which ensures precise alignment of commissural and coronary access, and discusses the precise sizing, positioning, and deployment of Octacor THV.
Management of stent failures
18 May 2023 – From EuroPCR 2023
Join us as we navigate the complexities of stent failures in this session and explore the diverse strategies employed for successful outcomes: learn about the challenges posed by in-stent restenosis following chimney stenting during valve-in-valve TAVI, delve into the dilemma of underexpanded stent restenosis and weigh the...
Contemporary best clinical practice for TAVI
18 May 2023 – From EuroPCR 2023
This interactive session is designed to show how a good pre-procedural assessment can facilitate the planning of a procedure. It also shows how a certain valve can be best suited for patients with certain phenotypes, and finally how to fully optimise the procedure to obtain the...
Managing a high bleeding risk patient undergoing PCI
15 Dec 2022 – From GulfPCR-GIM 2022
In this GulfPCR-GIM 2022 session, analyse the cases of a 76-year-old female patient with asthma, angina on exertion, multiple calcific tandem lesions in the LAD and LCX, and minimal RCA disease, and of a 48-year-old male patient, smoker, with ACS in 2012 and 2020, who presented with...
Rapid-fire clinical cases: Session 6
29 Nov 2022 – From PCR London Valves 2022
Discover a selection of abstracts presented during PCR LV 2022: valve-in-valve implant in a dysfunctional tricuspid bioprosthesis, first patient in TRICURE FIH trial, challenging percutaneous closure of prosthetic paravalvular leaks, and more!
Challenging scenarios: bicuspid aortic valves
28 Nov 2022 – From PCR London Valves 2022
Consult this session to learn more about the variety of bicuspid aortic valve phenotypes and their impact on procedural outcomes, the pre-procedural planning and optimal procedural technique in this challenging patient cohort, as well as the key considerations for TAVI in younger patients with a bicuspid aortic valve.
A patient with ACS – how should I treat the left main?
31 Oct 2022
Take a virtual trip to Chennai, India for this first PCR Webinar on the Road.
Precision PCI - Simplifying the complex - Learn from the masters
07 Oct 2022 – From AICT-ASIAPCR 2022
This session will help you better understand the influence of stent design, drug and polymer on the procedural short and long-term outcomes, the use of OCT in PCI of complex coronary lesions and the role, prevalence and diagnosis of microvascular dysfunction in patients with ischaemia and...
Treatment of calcified lesions
07 Oct 2022 – From AICT-AsiaPCR 2022
Consider a 66-year-old man, hypertensive and diabetic for 10 years, with history of recurrent substernal chest pain and exertional dyspnea, who presented with easy fatigability and shortness of breath, or a 72-year-old man on dialysis who presented with STEMI and severe calcified stenosis of LAD/DI bifurcation,...
Clinical cases - Structural interventions - Session 6
07 Oct 2022 – From AICT-AsiaPCR 2022
Beyond the guidelines of STEMI management: challenges in Southeast Asia
06 Oct 2022 – From AICT-AsiaPCR 2022
In this session, observe several challenging STEMI cases, such as a 48-year-old non-smoking Thai man with gout admitted for chest pain, or a 68-year-old woman with a history of HT, DM2, and PAD who presented with an anterior lateral STEMI and was indicated for PPCI, and...
